If you're a #Physician , #Nurse , #Pharmacist , or any #HCP involved in managing #oncology & #BMT , we've got something special for you!

Message us for a chat about our dedicated resource tailored just for you.

touchoncology.com/your-free-10-m…

The EBMT The EBMT_Nurses #MedEd #EBMT24 !

It’s Here! #EBMT24 !

Our team are excited for #EBMT24 and to unravel the latest clinical data and key presentations from the conference.

To keep up to date with our coverage, visit #touchONCOLOGY here: touchoncology.com/your-free-10-m…

The EBMT The EBMT_Nurses #MedEd #EBMT24

Are you ready for #EBMT24 tomorrow?

Don't miss out on the conversation, expert connections, and latest insights in #oncology & #BMT .

See you there!touchoncology.com/your-free-10-m… for on-demand content and keep up with all the latest insights.

The EBMT The EBMT_Nurses #MedEd

Can’t make #EBMT24 this weekend? Don’t worry! Secure your spot in our exclusive conference hub for on-demand access!

Dive into discussions led by top experts, catch up on hot topics, and stay updated on the latest trends: touchoncology.com/your-free-10-m…

The EBMT The EBMT_Nurses

Our publication on early breast cancer outcomes was published by JMIR Formative Research! 'Assessing Knowledge, Competence & Performance Following Web-Based Education' showcases the impact of our CME activities on HCPs' expertise in breast cancer management rb.gy/fuog9h #MedEd

Advancements in Non-metastatic, Muscle-invasive Bladder Cancer: Delve into Ongoing Studies Investigating Novel Approaches to Bladder Preservation.

Register now to continue reading: touchoncology.com/your-free-10-m…

#BladderCancer #MedicalResearch #CancerTreatment

Join us for #EBMT24 —an inspiring online journey through the global #oncology community, featuring cutting-edge scientific content on BMT and networking with top healthcare professionals celebrating The EBMT's 50-year achievements.

Register now: touchoncology.com/your-free-10-m…

Unlocking Immunotherapy Breakthroughs in Merkel Cell Carcinoma Treatment.

Discover the latest advancements and potential synergies with local therapies.

Register now: touchoncology.com/your-free-10-m…

#MerkelCellCarcinoma #Immunotherapy #CancerTreatment

Revisited...

Experts consider current unmet needs and possible future treatment directions for recurrent/metastatic SCCHN.

Watch now: touchoncologyime.org/future-treatme…

#HeadCancer
#NeckCancer
#Immunotherapy
#TargetedTherapies
#SCCHN

touchONCOLOGY are excited for #EBMT24 - from April 14 - 17, 2024

Don't miss out! Register with us today to get exclusive access to our conference hub, where you can dive into the latest on-demand content.

touchoncology.com/your-free-10-m…

The EBMT The EBMT_Nurses #MedEd #EBMT24

Have you seen our latest #YouTube video?

What’s on the horizon to tackle unmet needs in recurrent/metastatic SCCHN?

Watch now: youtu.be/0Kqx_jdFNaw

#HeadCancer
#NeckCancer
#Immunotherapy
#TargetedTherapies
#SCCHN

Revisited...

Dr Rebecca Heist discusses current and emerging antibody-drug conjugates for the second-line treatment of patients with advanced non-small cell lung cancer.

Watch now - touchoncologyime.org/emerging-secon…

#Lung Cancer
#Lung
#NSCLC
#ADCs
#CancerResearch

Exploring Advanced and Metastatic Gastrointestinal Stromal Tumours: Reviewing Current Knowledge and Latest Advances.

Register now for the latest insights on advanced and metastatic gastrointestinal stromal tumours! touchoncology.com/your-free-10-m…

#GIST #CancerResearch

Navigating Adjuvant Therapy for High-Risk Endometrial Cancer

Register now for the latest insights on adjuvant therapy for high-risk endometrial cancer! touchoncology.com/your-free-10-m…

#EndometrialCancer #AdjuvantTherapy

Have you seen our latest #YouTube video?

Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs

Watch now: youtu.be/sgqnNm-9bwY

#Lung Cancer
#Lung
#NSCLC
#ADCs
#CancerResearch

Exploring Cutting-Edge Checkpoint Inhibitors and Immunotherapies for Solid Tumors.

Our comprehensive review summarizes the latest data on these innovative treatment combinations.

Click here: touchoncology.com/immunotherapy/…

#CancerResearch #Immunotherapy

Exploring Novel Therapeutics for Non-metastatic Castrate-resistant Prostate Cancer. Discover the implications of advanced imaging modalities and future avenues for clinical research.

touchoncology.com/prostate-cance…

#ProstateCancer #MedicalAdvancements

Delve into the latest findings: Our systematic review on COVID Coagulopathy and Thrombosis sheds light on crucial insights.

Stay informed, stay ahead: touchoncology.com/covid-19/journ…

#COVIDResearch #ThrombosisReview

Revisited...

Experts share insights on the potential role of emerging protein degradation and immunomodulation therapies in RRMM.

Learn more with Prof. Cristina Gasparetto, Prof. Sagar Lonial and Prof. Sundar Jagannath.
touchoncologyime.org/protein-degrad…

#MultipleMyeloma

In this article, our objective is to assess the treatment options available for advanced MCC, with a specific emphasis on the latest developments in immunotherapy, including potential combinations with historical local therapies.

touchoncology.com/dermatological…